The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Women’s Health Diagnostics Market Research Report 2025

Global Women’s Health Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1898085

No of Pages : 86

Synopsis
Women’s health diagnostics market is growing due to the increasing prevalence of osteoarthritis, ovarian cancer, breast cancer and cervical cancer.
The global Women’s Health Diagnostics market was valued at US$ 27230 million in 2023 and is anticipated to reach US$ 43800 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
North America dominates the women's health diagnostics market owing to rising adoption of technologically advanced products. Moreover, government initiatives and product launches will further drive the growth of the women’s health diagnostics market in the region over the forecast period. The women's health diagnostics market in Asia Pacific is expected to witness substantial growth owing to improving healthcare infrastructure. In addition, initiatives taken by the government have increased women's participation in the workforce. Moreover, rising awareness about women's health disorders is expected to further drive the growth of the women's health diagnostics market in the region in the coming years.
This report aims to provide a comprehensive presentation of the global market for Women’s Health Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women’s Health Diagnostics.
Report Scope
The Women’s Health Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Women’s Health Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women’s Health Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Roche
Philips
Siemens
Perkinelmer Inc.
Alere Inc.
GE Healthcare
Becton, Dickinson and Company
Biomerieux SA
Quest Diagnostics Inc.
Hologic, Inc.
Segment by Type
Diagnostic Devices
Diagnostic Tests
Segment by Application
Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Women’s Health Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women’s Health Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostic Devices
1.2.3 Diagnostic Tests
1.3 Market by Application
1.3.1 Global Women’s Health Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Infectious Disease Testing
1.3.4 Osteoporosis Testing
1.3.5 Pregnancy and Fertility Testing
1.3.6 Sexually Transmitted Disease Testing
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Women’s Health Diagnostics Market Perspective (2019-2030)
2.2 Women’s Health Diagnostics Growth Trends by Region
2.2.1 Global Women’s Health Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Women’s Health Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Women’s Health Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Women’s Health Diagnostics Market Dynamics
2.3.1 Women’s Health Diagnostics Industry Trends
2.3.2 Women’s Health Diagnostics Market Drivers
2.3.3 Women’s Health Diagnostics Market Challenges
2.3.4 Women’s Health Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women’s Health Diagnostics Players by Revenue
3.1.1 Global Top Women’s Health Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Women’s Health Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Women’s Health Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Women’s Health Diagnostics Revenue
3.4 Global Women’s Health Diagnostics Market Concentration Ratio
3.4.1 Global Women’s Health Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women’s Health Diagnostics Revenue in 2023
3.5 Women’s Health Diagnostics Key Players Head office and Area Served
3.6 Key Players Women’s Health Diagnostics Product Solution and Service
3.7 Date of Enter into Women’s Health Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Women’s Health Diagnostics Breakdown Data by Type
4.1 Global Women’s Health Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Women’s Health Diagnostics Forecasted Market Size by Type (2025-2030)
5 Women’s Health Diagnostics Breakdown Data by Application
5.1 Global Women’s Health Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Women’s Health Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Women’s Health Diagnostics Market Size (2019-2030)
6.2 North America Women’s Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Women’s Health Diagnostics Market Size by Country (2019-2024)
6.4 North America Women’s Health Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Women’s Health Diagnostics Market Size (2019-2030)
7.2 Europe Women’s Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Women’s Health Diagnostics Market Size by Country (2019-2024)
7.4 Europe Women’s Health Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Women’s Health Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Women’s Health Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Women’s Health Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Women’s Health Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Women’s Health Diagnostics Market Size (2019-2030)
9.2 Latin America Women’s Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Women’s Health Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Women’s Health Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women’s Health Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Women’s Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Women’s Health Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Women’s Health Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Women’s Health Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Women’s Health Diagnostics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Women’s Health Diagnostics Introduction
11.2.4 Roche Revenue in Women’s Health Diagnostics Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Philips
11.3.1 Philips Company Detail
11.3.2 Philips Business Overview
11.3.3 Philips Women’s Health Diagnostics Introduction
11.3.4 Philips Revenue in Women’s Health Diagnostics Business (2019-2024)
11.3.5 Philips Recent Development
11.4 Siemens
11.4.1 Siemens Company Detail
11.4.2 Siemens Business Overview
11.4.3 Siemens Women’s Health Diagnostics Introduction
11.4.4 Siemens Revenue in Women’s Health Diagnostics Business (2019-2024)
11.4.5 Siemens Recent Development
11.5 Perkinelmer Inc.
11.5.1 Perkinelmer Inc. Company Detail
11.5.2 Perkinelmer Inc. Business Overview
11.5.3 Perkinelmer Inc. Women’s Health Diagnostics Introduction
11.5.4 Perkinelmer Inc. Revenue in Women’s Health Diagnostics Business (2019-2024)
11.5.5 Perkinelmer Inc. Recent Development
11.6 Alere Inc.
11.6.1 Alere Inc. Company Detail
11.6.2 Alere Inc. Business Overview
11.6.3 Alere Inc. Women’s Health Diagnostics Introduction
11.6.4 Alere Inc. Revenue in Women’s Health Diagnostics Business (2019-2024)
11.6.5 Alere Inc. Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Women’s Health Diagnostics Introduction
11.7.4 GE Healthcare Revenue in Women’s Health Diagnostics Business (2019-2024)
11.7.5 GE Healthcare Recent Development
11.8 Becton, Dickinson and Company
11.8.1 Becton, Dickinson and Company Company Detail
11.8.2 Becton, Dickinson and Company Business Overview
11.8.3 Becton, Dickinson and Company Women’s Health Diagnostics Introduction
11.8.4 Becton, Dickinson and Company Revenue in Women’s Health Diagnostics Business (2019-2024)
11.8.5 Becton, Dickinson and Company Recent Development
11.9 Biomerieux SA
11.9.1 Biomerieux SA Company Detail
11.9.2 Biomerieux SA Business Overview
11.9.3 Biomerieux SA Women’s Health Diagnostics Introduction
11.9.4 Biomerieux SA Revenue in Women’s Health Diagnostics Business (2019-2024)
11.9.5 Biomerieux SA Recent Development
11.10 Quest Diagnostics Inc.
11.10.1 Quest Diagnostics Inc. Company Detail
11.10.2 Quest Diagnostics Inc. Business Overview
11.10.3 Quest Diagnostics Inc. Women’s Health Diagnostics Introduction
11.10.4 Quest Diagnostics Inc. Revenue in Women’s Health Diagnostics Business (2019-2024)
11.10.5 Quest Diagnostics Inc. Recent Development
11.11 Hologic, Inc.
11.11.1 Hologic, Inc. Company Detail
11.11.2 Hologic, Inc. Business Overview
11.11.3 Hologic, Inc. Women’s Health Diagnostics Introduction
11.11.4 Hologic, Inc. Revenue in Women’s Health Diagnostics Business (2019-2024)
11.11.5 Hologic, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’